Cerity Partners’s Transmedics TMDX Stock Holding History

Cerity Partners’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,925	Closed	-$216K	–	3017
2025 Q3	$216K	Sell	1,925 -130	-6%	-$15.2K	﹤0.01%	2465
2025 Q2	$275K	Buy	+2,055	New	+$226K	﹤0.01%	2195

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Cerity Partners's TMDX Position: Q4 2025 in Review

Cerity Partners sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 1,925 shares — an estimated $216K sold.

Cerity Partners first reported a position in TMDX in Q2 2025 and held it in 2 quarters. The position peaked at $275K in Q2 2025. 428 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

Cerity Partners reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
Cerity Partners sold 1,925 Transmedics shares in Q4 2025, an estimated $216K.
Cerity Partners first reported a position in Transmedics in Q2 2025 and held it in 2 quarters.
Cerity Partners's Transmedics position peaked at $275K in Q2 2025.
428 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on Cerity Partners's 13F filing for Q4 2025, filed 11 Feb 2026.